On collaboration, computational chemistry, and cutting-edge AI – with Olga Nissan

At BIO-Europe Spring 2026 in Lisbon, Portugal, web editor Nicole Raleigh spoke with Dr Olga Nissan, vice president of business development at Evogene, a computational chemistry company, specialising in the generative design of small molecules for the pharmaceutical and agricultural industries. Nissan discusses recent developments at Evogene, including its extended collaboration with Google Cloud to develop and integrate AI agents into Evogene’s ChemPass AI platform, as well as its collaboration with Queensland University of Technology in the non-small cell lung cancer (NSCLC) space. She also speaks to where industry is at in its integration of cutting-edge AI into scientific research.